Related Experiment Video
Updated: Feb 27, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.4K
Diogenes Syndrome in Frontotemporal Dementia
Catherine M Finney1, Mario F Mendez2
11 University of Notre Dame, South Bend, IN, USA.
Summary
Diogenes syndrome, characterized by self-neglect and hoarding, is linked to behavioral variant frontotemporal dementia (bvFTD). Frontal lobe dysfunction may explain these symptoms, offering insights into potential treatments.
Area of Science:
- Neuroscience
- Geriatric Psychiatry
- Behavioral Neurology
Background:
- Diogenes syndrome involves extreme self-neglect, hoarding, and squalor, often seen in dementia.
- Behavioral variant frontotemporal dementia (bvFTD) may frequently present with Diogenes syndrome.
- Investigating bvFTD patients can elucidate the nature of Diogenes syndrome.
Purpose of the Study:
- To describe patients with bvFTD exhibiting self-neglect and hoarding.
- To explore the relationship between frontal lobe disturbances and Diogenes syndrome.
- To identify potential mechanisms and treatment avenues for Diogenes syndrome.
Main Methods:
- Case series of 5 patients with bvFTD showing self-care decline and hoarding.
- Literature review on Diogenes syndrome and frontotemporal dementia.
- Neuroanatomical and neurobehavioral analysis of frontal lobe functions.
Main Results:
- Patients with bvFTD displayed significant self-neglect and hoarding behaviors.
- Frontal lobe dysfunction, including loss of insight and compulsive drives, is implicated.
- A right frontolimbic-striatal system involvement is suggested in environmental dependency.
Conclusions:
- bvFTD provides a model for understanding Diogenes syndrome.
- Frontal lobe disturbances are key to the pathophysiology of Diogenes syndrome.
- Further research may lead to targeted therapeutic strategies for Diogenes syndrome.
Related Concept Videos
Dementia
609
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
609
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Dissociative Identity Disorder
1.2K
Dissociative Identity Disorder (DID), previously termed multiple personality disorder, is a complex psychological condition characterized by the presence of two or more distinct identities or personality states. Each identity exhibits unique patterns of behavior, voice, and mannerisms and may possess separate memories and emotional responses. The alternating control between identities can result in memory gaps and challenges in recalling daily activities, often exacerbating the individual's...
1.2K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K

